Search Results - "Aslamy, Arianne"

  • Showing 1 - 15 results of 15
Refine Results
  1. 1

    Exocytosis proteins as novel targets for diabetes prevention and/or remediation? by Aslamy, Arianne, Thurmond, Debbie C

    “…Diabetes remains one of the leading causes of morbidity and mortality worldwide, affecting an estimated 422 million adults. In the US, it is predicted that one…”
    Get more information
    Journal Article
  2. 2

    Steroid signaling mediates longevity responses to the eat-2 genetic model of dietary restriction in Caenorhabditis elegans by Farris, Mindy, Fang, Lily, Aslamy, Arianne, Pineda, Victor

    Published in Translational medicine of aging (2019)
    “…Dietary restriction (DR) extends lifespan in a wide range of model organisms, including Caenorhabditis elegans. It is an interesting but yet to be addressed…”
    Get full text
    Journal Article
  3. 3
  4. 4

    DOC2b Enhances β-Cell Function via a Novel Tyrosine Phosphorylation-Dependent Mechanism by Chatterjee Bhowmick, Diti, Aslamy, Arianne, Bhattacharya, Supriyo, Oh, Eunjin, Ahn, Miwon, Thurmond, Debbie C

    Published in Diabetes (New York, N.Y.) (01-06-2022)
    “…Double C2 domain Β (DOC2b) protein is required for glucose-stimulated insulin secretion (GSIS) in β-cells, the underlying mechanism of which remains…”
    Get full text
    Journal Article
  5. 5

    DOC2b Protects Functional Beta‐cell Mass via A Novel Tyrosine Phosphorylation Dependent Mechanism by Bhowmick, Diti Chatterjee, Aslamy, Arianne, Oh, Eunjin, Ahn, Miwon, Thurmond, Debbie C.

    Published in The FASEB journal (01-04-2020)
    “…Abstract only Type 2 diabetes (T2D) has reached the stage of a global pandemic. Approximately 10% of the total US population (~30 million people) are impacted…”
    Get full text
    Journal Article
  6. 6

    THU247 Characterizing Inpatient Cases Of DKA Precipitated By SGLT2 Inhibitor Use by Aslamy, Arianne, Nazemi, Reza, Tseng, Conrad, Kim, Steve, Gianchandani, Roma

    Published in Journal of the Endocrine Society (05-10-2023)
    “…Abstract Disclosure: A. Aslamy: None. R. Nazemi: Speaker; Self; Eli Lilly & Company, AstraZeneca. C. Tseng: None. S. Kim: None. R. Gianchandani: None…”
    Get full text
    Journal Article
  7. 7

    128-OR: DOC2b Boosts Insulin Secretion via a Yes Kinase-Dependent Mechanism by BHOWMICK, DITI CHATTERJEE, ASLAMY, ARIANNE, BHATTACHARYA, SUPRIYO, OH, EUNJIN, AHN, MIWON, THURMOND, DEBBIE C.

    Published in Diabetes (New York, N.Y.) (01-06-2021)
    “…Exocytosis regulatory protein DOC2b is a crucial regulator of SNARE assembly in β-cells and enrichment of DOC2b enhances glucose-stimulated insulin secretion…”
    Get full text
    Journal Article
  8. 8

    Increased Plasma Branched Short-Chain Fatty Acids and Improved Glucose Homeostasis: The Microbiome and Insulin Longitudinal Evaluation Study (MILES) by Aslamy, Arianne, Wood, Alexis C, Jensen, Elizabeth T, Bertoni, Alain G, Sheridan, Patricia A, Wong, Kari E, Ramesh, Gautam, Rotter, Jerome I, Chen, Yii-Der I, Goodarzi, Mark O

    Published in Diabetes (New York, N.Y.) (01-03-2024)
    “…Short-chain fatty acids (SCFAs) have been extensively studied for potential beneficial roles in glucose homeostasis and risk of diabetes; however, most of this…”
    Get full text
    Journal Article
  9. 9
  10. 10

    DOC2B promotes insulin sensitivity in mice via a novel KLC1-dependent mechanism in skeletal muscle by Zhang, Jing, Oh, Eunjin, Merz, Karla E., Aslamy, Arianne, Veluthakal, Rajakrishnan, Salunkhe, Vishal A., Ahn, Miwon, Tunduguru, Ragadeepthi, Thurmond, Debbie C.

    Published in Diabetologia (01-05-2019)
    “…Aims/hypothesis Skeletal muscle accounts for >80% of insulin-stimulated glucose uptake; dysfunction of this process underlies insulin resistance and type 2…”
    Get full text
    Journal Article
  11. 11

    Doc2b Protects β-Cells Against Inflammatory Damage and Enhances Function by Aslamy, Arianne, Oh, Eunjin, Olson, Erika M, Zhang, Jing, Ahn, Miwon, Moin, Abu Saleh Md, Tunduguru, Ragadeepthi, Salunkhe, Vishal A, Veluthakal, Rajakrishnan, Thurmond, Debbie C

    Published in Diabetes (New York, N.Y.) (01-07-2018)
    “…Loss of functional β-cell mass is an early feature of type 1 diabetes. To release insulin, β-cells require soluble -ethylmaleimide-sensitive factor attachment…”
    Get full text
    Journal Article
  12. 12

    The actin-related p41ARC subunit contributes to p21-activated kinase-1 (PAK1)–mediated glucose uptake into skeletal muscle cells by Tunduguru, Ragadeepthi, Zhang, Jing, Aslamy, Arianne, Salunkhe, Vishal A., Brozinick, Joseph T., Elmendorf, Jeffrey S., Thurmond, Debbie C.

    Published in The Journal of biological chemistry (17-11-2017)
    “…Defects in translocation of the glucose transporter GLUT4 are associated with peripheral insulin resistance, preclinical diabetes, and progression to type 2…”
    Get full text
    Journal Article
  13. 13

    Regulation of Insulin Sensitivity by Skeletal Muscle Specific Modulation Of p21‐Activated Kinase 1 (PAK1) by Salunkhe, Vishal Ashok, Tunduguru, Ragadeepthi, Ahn, Miwon, Olson, Erika M., Veluthakal, Rajakrishnan, Zhang, Jing, Aslamy, Arianne, Thurmond, Debbie C.

    Published in The FASEB journal (01-04-2018)
    “…Impaired skeletal muscle (skm) insulin signaling results in insulin resistance and the development of type 2 diabetes (T2D). Insulin binding to its receptors…”
    Get full text
    Journal Article
  14. 14

    Exocytosis Protein DOC2B as a Biomarker of Type 1 Diabetes by Aslamy, Arianne, Oh, Eunjin, Ahn, Miwon, Moin, Abu Saleh Md, Chang, Mariann, Duncan, Molly, Hacker-Stratton, Jeannette, El-Shahawy, Mohamed, Kandeel, Fouad, DiMeglio, Linda A, Thurmond, Debbie C

    “…Abstract Context Efforts to preserve β-cell mass in the preclinical stages of type 1 diabetes (T1D) are limited by few blood-derived biomarkers of β-cell…”
    Get full text
    Journal Article
  15. 15

    Doc2b Enhancement of Beta Cell Function and Survival by Aslamy, Arianne

    Published 01-01-2018
    “…Diabetes mellitus is a complex metabolic disease that currently affects an estimated 422 million people worldwide, with incidence rates rising annually. Type 1…”
    Get full text
    Dissertation